Hansen, Mathias Lühr http://orcid.org/0000-0003-1957-7005
Pellicer, Adelina
Gluud, Christian
Dempsey, Eugene
Mintzer, Jonathan
Hyttel-Sorensen, Simon
Heuchan, Anne Marie
Hagmann, Cornelia
Dimitriou, Gabriel
Pichler, Gerhard
Naulaers, Gunnar
Cheng, Guoqiang
Vilan, Ana
Tkaczyk, Jakub
Kreutzer, Karen B.
Fumagalli, Monica
Claris, Olivier
Fredly, Siv
Szczapa, Tomasz
Lange, Theis
Jakobsen, Janus Christian
Greisen, Gorm
Funding for this research was provided by:
Elsass Foundation (18-3-0133)
Article History
Received: 2 May 2019
Accepted: 25 September 2019
First Online: 19 December 2019
Ethics approval and consent to participate
: By 15 March 2019, the trial had been approved in 55 neonatal intensive care units in Austria, China, Czech Republic, Denmark, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland and Turkey. No sites will start randomising participants before ethics approval has been granted. Status on ethical approval for all participating sites can be found at ExternalRef removed.Written informed consent will be obtained by a qualified physician or nurse connected to the trial prior to randomisation of any participant, unless the neonatal intensive care unit (NICU) uses deferred informed consent or prior assent as consent methods. These consent procedures will be approved by local ethics committees or institutional review boards before use.
: Not applicable.
: The authors declare that they have no competing interests.